Source: Annual Congress 2012 - Early detection of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
M. Peres Rangel, V. Karen de Sá, J.R. Maciel Martins, E.R. Parra Cuentas, R. Vieira Reis, A. Longatto Filho, T. Takagaki, H. Nader, V.L. Capelozzi (Sao Paulo, , Barretos, Brazil). Hyaluronan: A novel sputum marker for the screening and diagnosis of lung cancer patients. Eur Respir J 2012; 40: Suppl. 56, 1643

Member's Comments

No comment yet.

Related content which might interest you: Induced sputum in the diagnosis of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 299s Year: 2004 Screening and diagnosis of lung cancer Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer Year: 2013 Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 The diagnostic value of serum tumor markers in newly diagnosed lung cancer patients Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Validation of diagnostic molecular markers in bronchial fluid for lung cancer Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer Year: 2011 The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 The diagnostic relevance of cytologic examination of induced sputum in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 299s Year: 2004 Shox2, a biomarker for confirming malignancy in bronchial lavage from patients with suspected lung cancer and inconclusive cytology Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer Year: 2009 Dealys in the diagnosis and treatment of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 458s Year: 2004 The clinical value of autofluorescence bronchoscopy for the diagnosis of lung cancer Source: Eur Respir J 2006; 28: 915-919 Year: 2006 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Screening for lung cancer Source: Eur Respir Mon; 2009: 44: 57–70 Year: 2009 Lung function testing for the preoperative evaluation of patients with lung cancer Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients Year: 2003 Comparison of induced and spontaneous sputum in the diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 64s Year: 2001 Prevalence and characterization of interstitial lung disease in a lung cancer screening program Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Role of progestrin releasing peptide (ProGRP), a serum based biomarker in early diagnosis of SCLC in cohort of high-risk patient presenting with symptoms related to lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Are there potential characteristical markers in bronquial fluid for diagnosis of small cell lung cancer (SCLC)? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Early detection of lung cancer: role of biomarkers Source: Eur Respir J 2003; 21: 36S-44S Year: 2003